ISSN: 8755-6863

Journal Home

Journal Guideline

Pediatric Pulmonology Q1 Unclaimed

John Wiley and Sons Inc. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Pediatric Pulmonology is a journal indexed in SJR in Pulmonary and Respiratory Medicine and Pediatrics, Perinatology and Child Health with an H index of 120. It has a price of 2650 €. It has an SJR impact factor of 0,907 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 0,907.

Pediatric Pulmonology focuses its scope in these topics and keywords: children, cystic, fibrosis, pulmonary, asthma, pediatric, infants, inhaled, aeruginosa, obstructive, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Pediatrics, Perinatology and Child Health (Q1) Pulmonary and Respiratory Medicine (Q2)

Price

2650 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

0,907

SJR Impact factor

120

H Index

533

Total Docs (Last Year)

1537

Total Docs (3 years)

14629

Total Refs

3785

Total Cites (3 years)

1251

Citable Docs (3 years)

2.43

Cites/Doc (2 years)

27.45

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Lancet Respiratory Medicine,The Q1
The Lancet Respiratory Medicine Q1
Journal of Thoracic Oncology Q1
American Journal of Respiratory and Critical Care Medicine Q1
European Respiratory Journal Q1

Compare this journals

Aims and Scope

Best articles by citations

Exhaled gas analysis and airway inflammation

Aortic hiatus gastric hernia

Risks and complications of nonbronchoscopic bronchoalveolar lavage in a pediatric intensive care unit

Defensins & other peptides

Modifier genes in cystic fibrosis

MucoidInquilinus limosusin a young adult with cystic fibrosis

Prevention of sudden infant death syndrome

Efficacy and safety of ipratropium bromide plus fenoterol inhaled via Respimat¬Æ Soft Mist‚Ñ¢ Inhaler vs. a conventional metered dose inhaler plus spacer in children with asthma

Facemasks and facial deposition of aerosols

Foreword

Azithromycin does not improve disease course in hospitalized infants with respiratory syncytial virus (RSV) lower respiratory tract disease: A randomized equivalence trial

Predictors of major intervention in infants with bronchiolitis

SHOW MORE ARTICLES

Pulmonary complications of HIV

HIV and the lung in developing world

New treatments for pediatric sinusitis

Early interventions in CF

Prevention strategies of chronic lung disease

Protective value of BCG vaccination in children in Bangkok, Thailand

Prospects for a parainfluenza virus vaccine

The delivery of proteins and peptides to the lung

Inhaled antibiotics

Distribution and transmission ofPseudomonas aeruginosa andBurkholderia cepacia in a hospital ward

Message of the President

Relationship between passive smoking exposure and urinary heavy metals and lung functions in preschool children